Skip to main content
Premium Trial:

Request an Annual Quote

Utrecht University to Use GeneGo's MetaDrug in Master's Program


NEW YORK (GenomeWeb News) - Utrecht University will use GeneGo’s MetaDrug software and database platform in its master’s program for drug innovation, GeneGo said today.
 
MetaDrug is designed to predict human metabolism, toxicity, and biological effects of small-molecule compounds.
 
"Academia pushes the limits of MetaDrug,” said Julie Bryant, GeneGo’s vice president of business development, in a statement, because it “allows us to further adapt it for new areas of medicinal chemistry.”
 
Financial terms of the agreement were not released.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.